NCT02160691View on ClinicalTrials.gov

Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2020

Study Completion Date

November 30, 2021

Conditions
Autism Spectrum Disorder
Interventions
DEVICE

Anxiety Meter

This is a new device developed to measure changes in heart rate and translate these into a visual display of arousal level in children with autism spectrum disorder.

Trial Locations (1)

M4G1R8

Holland Bloorview Kids Rehabilitation Hospital, Toronto

All Listed Sponsors
lead

Holland Bloorview Kids Rehabilitation Hospital

OTHER

NCT02160691 - Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter